Cationic Ring-Opening Polymerization for Uniform Polyoxazoline Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current polymer carriers for drug delivery, such as PEG and polyoxazolines, face challenges including immunogenicity, toxicity, polydispersity, and difficulty in achieving high molar mass with low dispersity, which are essential for biomedical applications.
Innovation Solution
A method involving cationic ring-opening polymerization of cyclic imino ether monomers is developed, which includes steps to remove impurities and perform polymerization at low temperatures, resulting in high molar mass polymers with narrow molecular weight distribution and low dispersity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional polymerization methods are used to produce high molar mass polymers, then molar mass increases, but dispersity increases (polydispersity broadens)
Solution Approach 1:
The patent applies preliminary action by removing impurities from the monomer before polymerization begins. This pre-cleaning step prevents side reactions and chain termination events that would otherwise cause dispersity to increase as molar mass builds up during polymerization.
Solution Approach 2:
The patent employs parameter changes by conducting polymerization at low temperatures (e.g., -78°C to 0°C) and using specific catalyst systems. These parameter changes suppress unwanted side reactions and chain transfer events, allowing high molar mass polymers to form while maintaining narrow dispersity.
2Quantity of substance
If polymerization is conducted to achieve high molar mass, then chain length increases, but side reactions and chain termination increase
Solution Approach 1:
The patent creates an inert environment by removing water and oxygen from the reaction system through molecular sieves, drying agents, and inert atmosphere techniques. This prevents unwanted side reactions with moisture and oxygen that would terminate chains and reduce polymer uniformity during high molar mass formation.
Solution Approach 2:
The patent uses specific catalyst systems and chain transfer agents as intermediaries to control the polymerization process. These intermediaries enable continuous chain growth to high molar masses while maintaining uniformity by regulating propagation and termination events.
3Reliability
If PEG is used as a polymer carrier, then drug solubility and circulating half-life improve, but immunogenicity and toxicity increase
Solution Approach 1:
The patent replaces PEG with polyoxazoline polymers that are biocompatible and non-immunogenic. While PEG provides good pharmacokinetic properties, it causes immunogenicity and toxicity at high molecular weights. The polyoxazoline alternative maintains the beneficial pharmacokinetic effects without the harmful immunogenic responses.
4Productivity
If impurities are present in the reaction mixture, then polymerization proceeds, but side reactions cause chain termination and reduce molar mass
Solution Approach 1:
The patent applies preliminary action by thoroughly purifying monomers and removing impurities before polymerization begins. This pre-cleaning ensures that polymerization proceeds at high rates without impurity-induced chain termination, enabling achievement of high molar masses.
Solution Approach 2:
The patent creates an inert environment using molecular sieves, drying agents, and exclusion of atmospheric contaminants. This prevents impurity introduction during polymerization, maintaining both high polymerization rates and high final molar masses by avoiding chain termination events.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method produces uniform polymers with high molar mass and low dispersity, suitable for biomedical applications, reducing the risk of immunogenicity and toxicity, and enabling improved drug delivery by minimizing side reactions and chain termination.
Implementation Method 1
polymerizing cyclic imino ether monomer in the first reaction mixture by cationic ring opening polymerization to produce a polymerized first reaction mixture
Data Source
AI summary
A method for production of a uniform polymer of high molar mass is provides, the method comprising: (a) polymerizing cyclic imino ether monomer in a first reaction mixture by cationic ring opening polymerization to produce a polymerized first reaction mixture containing (i) polymerized material and (ii) solvent and/or unreacted cyclic imino ether monomer; (b) separating solvent and/or unreacted cyclic imino ether monomer from polymerized material contained in the polymerized first reaction mixture; (c) copolymerizing by cationic ring opening polymerization a second liquid reaction mixture containing cyclic imino ether monomer and solvent by combining the separated unreacted cyclic imino ether monomer and/or the separated solvent with other components. Also disclosed are polyoxazoline polymers comprising at least 50 wt. % of repeating units derived from a 2-substituted 2-oxazoline monomer selected from 2-methyl-2-oxazoline, 2-ethyl-2-oxazoline, 2-n-propyl-2-oxazoline, 2-i-propyl-2-oxazoline and combinations thereof, said polymer having a DP of at least 250 and a very low dispersity.